Remove about
article thumbnail

Public Health Product Hops

Bill of Health

Dmitry’s talk, “Evergreening: The FDA’s Role in the Creation of Balanced Rights for Pharmaceutical Improvements,” was developed into an article and published in the Iowa Law Review in 2019 titled “The More Things Change: Improvement Patents, Drug Modifications, and the FDA.”

article thumbnail

FDA enables abortion via telemedicine by lifting restrictions on pill

Healthcare IT News - Telehealth

"The in-person dispensing requirements on medication abortion care have proven to be unnecessary during the pandemic, and the FDA did the right thing today by lifting them," said Kirsten Moore, director of the Expanding Medication Abortion Access Project, in a statement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is Preemption the Cure for Healthcare Federalism’s Restrictions on Medication Abortion?

Bill of Health

Now more than ever, a person’s access to abortion and other essential reproductive health care services depends on their state of residence and whether they have the means to travel to a state that protects access to abortion care. Food and Drug Administration (FDA) is now top of mind for lawyers, scholars, policymakers, and the public.

FDA 176
article thumbnail

How Will New FDA Hearing Aid Regulations Impact Health Plans?

HIT Consultant

First, let’s examine the new regulatory framework the FDA established. Health plans offering the OTC benefit can also leverage the opportunity to educate members about the significant role hearing aids can play in improving their overall health. About Thomas Tedeschi. – What new opportunities will arise?

FDA 98
article thumbnail

Preparing for the End of the Public Health Emergency

YouCompli

In this article, she discusses several issues that hospitals and health systems need to consider as a result of the scheduled end of the COVID-19 public health emergency. Department of Health & Human Services (HHS) reports that 80% of the U.S. population previously received at least one COVID-19 vaccination.

article thumbnail

Psychedelics Are Cheap. Psychedelic Treatment Is Not.

Bill of Health

Think about it: a psychedelic “trip” can take several hours. The FDA approved S-ketamine to treat depression in 2019. Compare those prices to those charged by Joyous, a telehealth company that ships ketamine directly to customers for about $130 per month. first appeared on Bill of Health. The post Psychedelics Are Cheap.

FDA 261
article thumbnail

HIMSSCast: Predicting what's next for health IT, mobile tech and health system finances

Healthcare It News

Talking points: The future of the Public Health Emergency and the flexibilities it allows. A "perfect storm" of financial stress for hospitals and health systems. FDA and evolving regulations for digital therapeutics, software as a medical device. Like what you hear? Labor shortages and supply chain challenges.

COVID-19 283